✉news HealthMedicine first seen 18 h ago, last 18 h ago, peak #28

Lab-Grown Tumor Organoids Test Glioblastoma Treatments

Original: Patient-Derived GBM Organoid Platform Probes Radiation and Drug Responses

Researchers have developed a patient-derived organoid platform for glioblastoma, allowing lab-grown replicas of individual brain tumors to be tested against radiation and drug therapies. The approach aims to reveal how a patient's specific tumor responds to treatment before clinical decisions are made, in a cancer where options remain limited and prognosis is typically poor.

Why now: Glioblastoma has few effective treatments, so a platform that personalizes radiation and drug testing offers hope for better-targeted care.

glioblastomaInside Precision Medicine

Open on news →

Evidence

• Patient-Derived GBM Organoid Platform Probes Radiation and Drug Responses · Inside Precision Medicine

API: https://socialmediatrends-api.osmike.com/v1/trends/1380794